LGT CAPITAL PARTNERS LTD. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 271 filers reported holding HAEMONETICS CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
LGT CAPITAL PARTNERS LTD. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$10,023,823
+5.2%
111,8980.0%0.36%
+9.7%
Q2 2023$9,526,996
-40.2%
111,898
-41.9%
0.33%
-25.7%
Q1 2023$15,925,982
-31.9%
192,459
-35.3%
0.44%
-35.2%
Q4 2022$23,396,723
-59.0%
297,479
-61.4%
0.68%
-60.8%
Q3 2022$57,076,000
-11.4%
770,989
-22.0%
1.74%
-10.9%
Q2 2022$64,408,000
+5.4%
988,149
+2.2%
1.96%
+12.8%
Q1 2022$61,102,000
-5.3%
966,499
-20.5%
1.74%
+1.3%
Q4 2021$64,500,000
-22.5%
1,216,059
+3.1%
1.72%
-31.7%
Q3 2021$83,272,000
+31.1%
1,179,659
+23.7%
2.51%
+39.6%
Q2 2021$63,536,000953,4251.80%
Other shareholders
HAEMONETICS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders